Clinical trial
Cannabinoid-Based Therapy and Approaches to Quantify Pain in Sickle Cell Disease
NCT01771731 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cannabinoid-Based Therapy and Approaches to Quantify Pain in Sickle Cell Disease
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- May 19, 2017
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease